Characterizing a murine breast cancer mouse model reveals chromosomal abnormalities in structure and number of single‐cell clones and the presence of rare cancer stem cell‐like phenotypes
Animal Models and Experimental Medicine · 2026-02 · 9 (2) · 367-377
DOI: 10.1002/ame2.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 27.02.2026. Verfasst von Quy Van-Chanh Le und 11 weiteren Autor:innen. Beteiligte Einrichtung: Future Industries Institute, Adelaide University, Mawson Lakes, South Australia, Australia. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Chromosome Aberrations, Mammary Neoplasms, Experimental, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research, Development and Innovation Fund of the Ministry of Culture and Innovation under the National Laboratories Program (National Tumor Biology La…, Senior Research Fellowship from National Health and Medical Research Council of Australia, Hungarian Thematic Excellence Program.
Abstract (Originalsprache)
Realistic models for cancer research representing disease progression that commensurately respond to therapeutics consistent with clinical observation are the holy grail for pre‐clinical research and screening. Although such an ideal is elusive, well‐characterized in vivo models facilitate our understanding of disease, progression, and therapeutic opportunities. Here, we characterize a commonly used syngeneic BALB/c mouse model of triple negative breast cancer (4T1) after establishing tumors in their flanks. Tumors developed at the subcutaneous injection site for all experimental mice and their volumes were monitored. We quantified a rare subset of breast cancer stem‐like cells (CSCs), classified as CD44 + /CD24 − phenotypes in in vitro and ex vivo cell populations. Chromosome numbers in ex vivo metaphase cells were greater than cells cultured in vitro (89.4 ± 3.4, range of 70–132 and 82.6 ± 1.1, range of 70–128; respectively). Further, we observed different types of chromosome aberrations, including gap, deletion, exchange, interstitial deletion, terminal deletion, ring, dicentric, and Robertsonian translocations. For both sources of cells, the number of aberrations was dominated by deletions, terminal deletions, and Robertsonian translocations. Ex vivo cells exhibited greater prevalence of deletions and terminal deletions, whereas in vitro cells displayed more ring aberrations and Robertsonian translocations. In conclusion, we successfully characterized cancer cells from a syngeneic mouse model of breast cancer in terms of rare CSC proportion and a variety of chromosomal aberrations, which is useful for understanding tumor traits associated with cancer development and therapeutic action. The data act as a valuable resource for other studies using the 4T1 BALB/c model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Future Industries Institute, Adelaide University, Mawson Lakes, South Australia, Australia.
- School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, South Australia, Australia.
- Department of Radiobiology and Diagnostic Onco-Cytogenetics, Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary.
- Centre for Cancer Biology, Adelaide University and SA Pathology, Adelaide, South Australia, Australia.
- School of Physics, Chemistry & Earth Science, College of Science, Adelaide University, Adelaide, South Australia, Australia.
- Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
ORCID-Profile: Ivan Kempson
Förderung
- National Research, Development and Innovation Fund of the Ministry of Culture and Innovation under the National Laboratories Program (National Tumor Biology La…
- Senior Research Fellowship from National Health and Medical Research Council of Australia
- Hungarian Thematic Excellence Program
- Tour de Cure, Pioneering Grant
- Tour de Cure
Zitieren
APA
Le, Q. V., Kocsis, Z. S., Liang, S., Li, Y., Gliddon, B. L., Bailey, S., Nguyen, A. T., Turnbull, T., Pitson, S. M., Jurányi, Z., Le, H., & Kempson, I. (2026). Characterizing a murine breast cancer mouse model reveals chromosomal abnormalities in structure and number of single‐cell clones and the presence of rare cancer stem cell‐like phenotypes. Animal Models and Experimental Medicine, 9(2), 367-377. https://doi.org/10.1002/ame2.70156
Vancouver
Le QV, Kocsis ZS, Liang S, Li Y, Gliddon BL, Bailey S, et al. Characterizing a murine breast cancer mouse model reveals chromosomal abnormalities in structure and number of single‐cell clones and the presence of rare cancer stem cell‐like phenotypes. Animal Models and Experimental Medicine. 2026;9(2):367-377. doi:10.1002/ame2.70156
BibTeX
@article{Le2026,
author = {Le, Quy Van-Chanh and Kocsis, Zsuzsa S and Liang, Sisi and Li, Yanrui and Gliddon, Briony L and Bailey, Sheree and Nguyen, Anh Thai-Quynh and Turnbull, Tyron and Pitson, Stuart M and Jurányi, Zsolt and Le, Hien and Kempson, Ivan},
title = {Characterizing a murine breast cancer mouse model reveals chromosomal abnormalities in structure and number of single‐cell clones and the presence of rare cancer stem cell‐like phenotypes},
journal = {Animal Models and Experimental Medicine},
year = {2026},
volume = {9},
number = {2},
pages = {367--377},
doi = {10.1002/ame2.70156}
}
EUVIMED